Recap: Amryt Pharma Q3 Earnings

Amryt Pharma AMYT reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Amryt Pharma missed estimated earnings by 20.0%, reporting an EPS of $-0.06 versus an estimate of $-0.05.

Revenue was up $4.61 million from the same period last year.

Last quarter the company beat on EPS by $0.03 which was followed by a 1.29% increase in the share price the next day.

Here's a look at Amryt Pharma's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	-0.05	-0.02	-0.15	-0.17
EPS Actual	-0.02	-0.05	-0.07	-0.07
Revenue Estimate	64.23M	58.12M	56.81M	52.78M
Revenue Actual	68.54M	59.13M	54.83M	56.52M

To track all earnings releases for Amryt Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.